
On September 21, the 2Firsts team discovered that some brand manufacturers had taken advantage of the popularity of nicotine pouches at the tobacco expo in Dortmund, Germany, by introducing a similar product called nicotine oral film.

Avoid the market for nicotine pouches.

At the NUSO company booth, it was discovered that they were showcasing their Orgco brand nicotine oral films. According to booth staff, the product is designed to differentiate itself from the competitive nicotine pouch market.

According to the booth staff, faced with the oversaturated nicotine pouch market, the company has decided not to compete directly, but instead to introduce this more discreet and convenient alternative nicotine product.

According to reports, the nicotine oral film of the orgco brand is produced in the company's factory in Indonesia, with a nicotine content of 2% in the product. Although it has not yet undergone large-scale marketing, the volume of inquiries during the exhibition period has been "quite substantial." One audience member who experienced it on-site commented that the nicotine oral film, compared to other nicotine replacement products on the market, still needs time to be tested by the market.

Currently, the brand's products have not yet been officially launched on the market.
In addition, the two leaders also noticed several other nicotine oral film products. China Boton Group showcased a nicotine oral film called "ECHI" at their booth, these products were displayed alongside the brand's nicotine pouches on the display table.
Another brand called "melta" offers a variety of flavored nicotine oral films to choose from. The brand's representatives stated that their products are already on the market and selling well in Europe and the United States.
The product's mechanism of action is similar to that of a nicotine pouch.
The core technology of nicotine oral film lies in its fast-dissolving design. Two recent patent searches have revealed that "nicotine dissolvable film with or without mint flavor" is a type of rapidly dissolving film placed in the mouth, containing "nicotine or nicotine analogs, with or without mint flavor or mint flavor analogs". It can be directly absorbed into the bloodstream through the oral mucosa, with the purpose of satisfying temporary nicotine cravings when unable to smoke, or for therapeutic purposes.
Nicotine pouches are also absorbed through the oral mucosa, and they share similarities with traditional snus in terms of usage. However, nicotine pouches require saliva in order for the nicotine to be released more effectively, which is then absorbed through the oral mucosa.
Compared to nicotine pouches and other oral tobacco products, the advantage of nicotine oral film is that the product does not need to be spit out after use.
Like with a nicotine pouch, you may need to eventually spit out the packaging, but with this nicotine oral film, it simply dissolves and doesn't need to be spit out, that's the advantage," explained a representative of the brand.
According to a study, although nicotine oral films have been introduced in the European and American markets, concerns about side effects and efficacy still exist in the market, especially when users experience common discomforts such as palpitations and throat irritation.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.